Dermatite atopique : évaluation de la perception d’un plan d’action personnalisé auprès de pédiatres libéraux

Gabeff, R.; Assathiany, R.; Barbarot, S.; Salinier, C.; Stalder, J.F.

doi:10.1016/j.arcped.2014.04.019

Cited by 3 publications

(8 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For the care of children in an outpatient setting, written treatment instructions may be very useful. Positive experiences have been reported with the ‘Personalized Written Action Plan for Atopics’ …”

Section: Specific Considerations For Childrenmentioning

confidence: 99%

“…Positive experiences have been reported with the 'Personalized Written Action Plan for Atopics'. 172 Systemic treatment for children is administered on a patient individual basis in severe cases, and there is no consented standard treatment for the substances or the duration. The most commonly used drug in Europe is CyA, followed by SCS and AZA.…”

Section: Specific Considerations For Childrenmentioning

confidence: 99%

See 1 more Smart Citation

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

Wollenberg

Oranje²,

Deleuran

et al. 2016

Acad Dermatol Venereol

Self Cite

354

488

View full text Add to dashboard Cite

Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin disease of children and adults. The diagnosis is made using evaluated clinical criteria. Disease activity is best measured with a composite score assessing both objective signs and subjective symptoms, such as SCORAD. The management of AD must consider the clinical and pathogenic variabilities of the disease and also target flare prevention. Basic therapy includes hydrating topical treatment, as well as avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment of visible skin lesions is based on topical glucocorticosteroids and the topical calcineurin inhibitors tacrolimus and pimecrolimus. Topical calcineurin inhibitors are preferred in sensitive locations. Tacrolimus and mid-potent steroids are proven for proactive therapy, which is long-term intermittent anti-inflammatory therapy of the frequently relapsing skin areas. Systemic anti-inflammatory or immunosuppressive treatment is indicated for severe refractory cases. Biologicals targeting key mechanisms of the atopic immune response are promising emerging treatment options. Microbial colonization and superinfection may induce disease exacerbation and can justify additional antimicrobial treatment. Systemic antihistamines (H1R-blockers) may diminish pruritus, but do not have sufficient effect on lesions. Adjuvant therapy includes UV irradiation, preferably UVA1 or narrow-band UVB 311 nm. Dietary recommendations should be patient specific and elimination diets should only be advised in case of proven food allergy. Allergen-specific immunotherapy to aeroallergens may be useful in selected cases. Psychosomatic counselling is recommended to address stress-induced exacerbations. 'Eczema school' educational programmes have been proven to be helpful for children and adults.

show abstract

Section: Specific Considerations For Childrenmentioning

confidence: 99%

Section: Specific Considerations For Childrenmentioning

confidence: 99%

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

Wollenberg

Oranje²,

Deleuran

et al. 2016

Acad Dermatol Venereol

Self Cite

354

488

View full text Add to dashboard Cite

show abstract

“…The characteristics of the nine included studies are summarized in 24,31,32 represented the views of parents and carers, two school nurses, 25,29 two studies HCPs, 28,30 and two studies mixed stakeholder groups of homeless parents and shelter staff 26 and parents, school nurses, school personnel and clinic health professionals. 27 Six studies were conducted in the USA, including all of the studies in school settings/incorporating the views of school nurses.…”

Section: Characteristics Of Included Papersmentioning

confidence: 99%

“…Instructions may not be followed because they are not understood. Five studies [27][28][29]31,32 suggested that provision of a WAP alone is not sufficient to enable people to provide appropriate care for a child and that there was a need for training to understand both the WAP and the condition. Three of these four studies focused on schools 27,29 and homeless shelters.…”

Section: Valuing and Using Wapsmentioning

confidence: 99%

See 1 more Smart Citation

Written action plans for children with long‐term conditions: A systematic review and synthesis of qualitative data

Waldecker

Malpass

King

et al. 2017

Health Expectations

View full text Add to dashboard Cite

BackgroundLong‐term conditions (LTCs) in children require a high level of self‐management. Written action plans (WAPs) have been advocated to guide decision‐making and support self‐management but there is uncertainty about how WAPs “work” and what aspects are important for successful implementation.ObjectiveTo review and synthesize existing qualitative evidence about the design and use of WAPs across childhood LTCs.MethodWe undertook a systematic search of the literature (Medline, EMBASE, CiNAHL, PsycInfo, Web of science) from inception to May 2015; critically appraised included studies; and synthesized the findings, drawing on normalisation process theory.Results3473 titles were screened and 53 papers read in full. Nine studies (four key, two minor and three of poor quality) contributed to our analysis, predominantly work on asthma from the USA and in specialist settings. WAPs may help to alleviate user worry and boost confidence. Confidence to act was closely linked to feelings of responsibility and authority. The value and use of WAPs are determined by multiple factors, and varies between different user groups. Logistical challenges include sharing a WAP between different stakeholders and keeping it up to date. Colour coding and pictures may enhance the appeal and usability of WAPS.Conclusion WAPs are complex interventions but our understanding of their use and value in children with LTCs is limited. WAPs need to meet the needs of users who have different requirements/levels of understanding and confidence according to their different roles. Future research into WAPs needs to be both disease and context‐specific.

show abstract

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Wollenberg

Christen-Zäch

Taı̈eb

et al. 2020

Acad Dermatol Venereol

Self Cite

246

360

View full text Add to dashboard Cite

Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis is made using evaluated clinical criteria. Disease activity and burden are best measured with a composite score, assessing both objective and subjective symptoms, such as SCORing Atopic Dermatitis (SCORAD). AD management must take into account clinical and pathogenic variabilities, the patient's age and also target flare prevention. Basic therapy includes hydrating and barrierstabilizing topical treatment universally applied, as well as avoiding specific and unspecific provocation factors. Visible skin lesions are treated with anti-inflammatory topical agents such as corticosteroids and calcineurin inhibitors (tacrolimus and pimecrolimus), which are preferred in sensitive locations. Topical tacrolimus and some mid-potency corticosteroids are proven agents for proactive therapy, which is defined as the long-term intermittent anti-inflammatory therapy of frequently relapsing skin areas. Systemic anti-inflammatory or immunosuppressive treatment is a rapidly changing † See Appendix section.

show abstract

Dermatite atopique : évaluation de la perception d’un plan d’action personnalisé auprès de pédiatres libéraux

Cited by 3 publications

References 22 publications

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

Written action plans for children with long‐term conditions: A systematic review and synthesis of qualitative data

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Contact Info

Product

Resources

About